NPR2 and infection: Two days after the infection, immunostaining with an anti-SeV antibody clearly demonstrated that 50% of PASMCs were infected with SeV vectors carrying wild-type (WT)-NPR2 and caNPR2, whereas the infectious ability of the control SeV vector (Azami-Green-carrying SeV, which is purchased ready to use) was higher (Figure 1a).